ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023

December 13, 2013

ASCO To Open Abstracts To Everyone Prior To Annual Meeting.

November 16, 2007

Frederick RFP Available Oct. 22; Three Four May Challenge L-B

August 27, 1976

UNM Gets $1.8 Million For Nanotechnology Center

February 18, 2011

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.

July 28, 2000